SV2003000995A - NEW ARILSULFONAMIDS AS ANTIVIRAL AGENTS REF. LEA35214-SV - Google Patents
NEW ARILSULFONAMIDS AS ANTIVIRAL AGENTS REF. LEA35214-SVInfo
- Publication number
- SV2003000995A SV2003000995A SV2002000995A SV2002000995A SV2003000995A SV 2003000995 A SV2003000995 A SV 2003000995A SV 2002000995 A SV2002000995 A SV 2002000995A SV 2002000995 A SV2002000995 A SV 2002000995A SV 2003000995 A SV2003000995 A SV 2003000995A
- Authority
- SV
- El Salvador
- Prior art keywords
- new
- antiviral agents
- lea35214
- arilsulfonamids
- agents ref
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
NUEVAS ARILSULFONAMIDAS COMO AGENTES ANTIVIRALESLA PRESENTE INVENCIÓN SE REFIERE A NUEVAS SULFONAMIDAS DE FÓRMULA GENERAL (I) (VER FORMULA), EN LA QUE LOS SUSTITUYENTES R1, R2, R3 Y R4, ASÍ COMO A Y X TIENEN LOS SIGNIFICADOS CITADOS, ASÍ COMO A PROCEDIMIENTOS PARA SU PREPARACIÓN Y A SU USO COMO AGENTES ANTIVIRALES, ESPECIALMENTE FRENTE A CITOMEGALOVIRUS.NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS THE PRESENT INVENTION REFERS TO NEW SULFONAMIDES OF GENERAL FORMULA (I) (SEE FORMULA), IN WHICH THE SUBSTITUTES R1, R2, R3 AND R4, AS WELL AS AYX HAVE THE MEANINGS AS APPOINTMENT TO PREPARATION AND ITS USE AS ANTIVIRAL AGENTS, ESPECIALLY AGAINST CITOMEGALOVIRUS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10119137 | 2001-04-19 | ||
DE10148598A DE10148598A1 (en) | 2001-04-19 | 2001-10-02 | New N-(acylaminophenyl)-heteroaryl-benzenesulfonamide derivatives, useful as antiviral agents, especially effective against human cytomegalovirus infections |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2003000995A true SV2003000995A (en) | 2003-03-18 |
Family
ID=7681939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2002000995A SV2003000995A (en) | 2001-04-19 | 2002-04-18 | NEW ARILSULFONAMIDS AS ANTIVIRAL AGENTS REF. LEA35214-SV |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR20030088509A (en) |
AR (1) | AR034309A1 (en) |
CO (1) | CO5540388A2 (en) |
DE (1) | DE10148598A1 (en) |
EC (1) | ECSP034813A (en) |
GT (1) | GT200200075A (en) |
PE (1) | PE20021061A1 (en) |
SV (1) | SV2003000995A (en) |
ZA (1) | ZA200307892B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7482366B2 (en) * | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
NZ537980A (en) * | 2002-08-23 | 2007-08-31 | Rigel Pharmaceuticals Inc | Pyridyl substituted heterocycles useful for treating or preventing HCV infection |
JP2006516250A (en) * | 2002-12-18 | 2006-06-29 | サイトビア インコーポレイティッド | 3,5-disubstituted- [1,2,4] -oxadiazoles and their derivatives and their use as caspase activators and apoptosis inducers |
DE10300109A1 (en) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Method for inhibiting replication of herpes viruses |
WO2004099165A2 (en) | 2003-05-02 | 2004-11-18 | Rigel Pharmaceuticals, Inc. | Heterocyclic compounds and hydro isomers thereof |
US8580842B2 (en) | 2003-09-30 | 2013-11-12 | Abbott Gmbh & Co. Kg | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
WO2005049065A2 (en) | 2003-11-19 | 2005-06-02 | Rigel Pharmaceuticals, Inc. | Synergistic combinations of dihaloacetamide with interferon or ribavirin for treatment hcv infections |
US7514434B2 (en) | 2004-02-23 | 2009-04-07 | Rigel Pharmaceuticals, Inc. | Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof |
WO2007027230A2 (en) | 2005-05-02 | 2007-03-08 | Rigel Pharmaceuticals, Inc. | Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
US8486979B2 (en) | 2006-12-12 | 2013-07-16 | Abbvie Inc. | 1,2,4 oxadiazole compounds and methods of use thereof |
UY30846A1 (en) | 2006-12-30 | 2008-07-31 | Abbott Gmbh & Amp | OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES |
US20080255203A1 (en) * | 2007-04-12 | 2008-10-16 | Abbott Laboratories | Heterocyclic compounds and their methods of use |
WO2010009775A1 (en) | 2007-12-07 | 2010-01-28 | Abbott Gmbh & Co. Kg | Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
WO2009071687A1 (en) | 2007-12-07 | 2009-06-11 | Abbott Gmbh & Co. Kg | Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
CA2707669C (en) | 2007-12-07 | 2016-07-05 | Wilfried Braje | 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
CA2707671C (en) | 2007-12-07 | 2016-02-02 | Abbott Gmbh & Co. Kg | 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
WO2010138600A2 (en) | 2009-05-29 | 2010-12-02 | Abbott Laboratories | Pharmaceutical compositions for the treatment of pain |
-
2001
- 2001-10-02 DE DE10148598A patent/DE10148598A1/en not_active Withdrawn
-
2002
- 2002-04-08 KR KR10-2003-7013617A patent/KR20030088509A/en not_active Application Discontinuation
- 2002-04-17 AR ARP020101392A patent/AR034309A1/en unknown
- 2002-04-18 GT GT200200075A patent/GT200200075A/en unknown
- 2002-04-18 PE PE2002000323A patent/PE20021061A1/en not_active Application Discontinuation
- 2002-04-18 SV SV2002000995A patent/SV2003000995A/en not_active Application Discontinuation
-
2003
- 2003-10-09 ZA ZA200307892A patent/ZA200307892B/en unknown
- 2003-10-17 EC EC2003004813A patent/ECSP034813A/en unknown
- 2003-11-19 CO CO03102172A patent/CO5540388A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ECSP034813A (en) | 2003-12-01 |
ZA200307892B (en) | 2004-10-11 |
PE20021061A1 (en) | 2002-12-12 |
CO5540388A2 (en) | 2005-07-29 |
KR20030088509A (en) | 2003-11-19 |
DE10148598A1 (en) | 2002-10-24 |
GT200200075A (en) | 2002-12-24 |
AR034309A1 (en) | 2004-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2003000995A (en) | NEW ARILSULFONAMIDS AS ANTIVIRAL AGENTS REF. LEA35214-SV | |
ECSP066541A (en) | NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA | |
BRPI0411528A (en) | use of isomalt as prebiotic | |
AR057325A1 (en) | SYNTHESIS OF (S) -N-METHYLNTREXONE, PHARMACEUTICAL COMPOSITIONS AND USES | |
PA8570901A1 (en) | DERIVATIVES OF ACIL-4-CARBOXIFENILUREA, PROCEDURES FOR PREPARATION AND USE | |
UY28342A1 (en) | NEW COMPOUNDS | |
ECSP045410A (en) | NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA | |
CR8824A (en) | DERIVATIVES OF 2-CARBAMIDA-4-FENILTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS | |
UY27263A1 (en) | NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS | |
GT200500238A (en) | SUBSTITUTED PHENYLAMINOTIAZOLS AND ITS USE | |
UY29795A1 (en) | ADENINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS | |
HN2002000300A (en) | NEW DERIVATIVES OF PIPERAZINA | |
SV1999000118A (en) | NEW SUBSTITUTED PIRAZOL DERIVATIVES REF. READ 33188-SV | |
ECSP034774A (en) | PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS | |
ECSP034773A (en) | PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS | |
CR8451A (en) | USE OF N-ARILHYDRACINE DERIVATIVES TO COMBAT PESTS | |
PA8575601A1 (en) | PROCEDURE FOR PREPARATION, MEDICATIONS THAT INCLUDE THESE COMPOUNDS AND THEIR USE | |
ECSP066304A (en) | COMPOUNDS | |
EA200700997A1 (en) | 2,5- and 2,6-DESIGNATED BENZAZOL ANALOGUES, USEFUL AS A PROTEINKINAZ INHIBITOR | |
CR8340A (en) | N-SUBSTITUTED PIRAZOLILCARBOXANILIDS | |
SV1999000006A (en) | NEW SULFONAMIDES NAFTIL- AND ANILIDO-SUBSTITUTED REF. READ 32809-SV | |
SV2006002220A (en) | DERIVATIVES OF ALQUILIDEN-TETRAHIDRONAFTALENO, PROCEDURE FOR THEIR PREPARATION AND ITS USE AS ANTI-INFLAMMATORY REF. P-SV-78.836 / CD | |
UY30356A1 (en) | DERIVATIVES OF 3-HALO-N- (2. (4-FLUOROPHENYL) -4-OXOBUTIL) -N-METIL-5- (TRIFLUOROMETIL) BENZAMIDE AND COMPOSITIONS OF THE SAME. | |
DE60031886D1 (en) | purine derivatives | |
AR027575A1 (en) | SUBSTITUTED BENZOILCICLOHEXENONAS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Lapse |